{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:48:33Z","timestamp":1790455713793,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01 DA036221"],"award-info":[{"award-number":["U01 DA036221"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a high risk of death from opioid overdose following release from prison. Efforts to develop and implement overdose prevention programs for justice-involved populations have increased in recent years. An understanding of the gaps in knowledge on prevention interventions is needed to accelerate development, implementation, and dissemination of effective strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search process identified 43 published papers addressing opioid overdose prevention in criminal justice settings or among justice-involved populations from 2010 to February 2020. Cross-cutting themes were identified, coded and qualitatively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Papers were coded into five categories: acceptability (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20098), accessibility (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20094), effectiveness (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20095), feasibility (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20097), and participant overdose risk (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200919). Common themes were: (1) Acceptability of naloxone is associated with injection drug use, overdose history, and perceived risk within the situational context; (2) Accessibility of naloxone is a function of the interface between corrections and community; (3) Evaluations of overdose prevention interventions are few, but generally show increases in knowledge or reductions in opioid overdose; (4) Coordinated efforts are needed to implement prevention interventions, address logistical challenges, and develop linkages between corrections and community providers; (5) Overdose is highest immediately following release from prison or jail, often preceded by service-system interactions, and associated with drug-use severity, injection use, and mental health disorders, as well as risks in the post-release environment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Study findings can inform the development of overdose prevention interventions that target justice-involved individuals and policies to support their implementation across criminal justice and community-based service systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-021-00346-1","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T05:02:58Z","timestamp":1613970178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A scoping review of factors that influence opioid overdose prevention for justice-involved populations"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-3248","authenticated-orcid":false,"given":"Christine E.","family":"Grella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ostlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy K.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis P.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"346_CR1","volume-title":"National Survey on Drug Use and Health, 2016","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality","year":"2017","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health, 2016. Ann Arbor: Inter-university Consortium for Political and Social Research; 2017. http:\/\/datafiles.samhsa.gov\/study-dataset\/national-survey-drug-use-and-health-2016-nsduh-2016-ds0001-nid17185. Accessed 24 Sep 2020"},{"issue":"3","key":"346_CR2","doi-asserted-by":"publisher","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","volume":"1","author":"T Winkelman","year":"2018","unstructured":"Winkelman T, Chamg VW, Binswanger IA. Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Netw Open. 2018;1(3):e180558.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"346_CR3","first-page":"06","volume":"5","author":"R Borschmann","year":"2019","unstructured":"Borschmann R, Tibble H, Spittal MJ, Pirkis J, Preen D, Larney S, et al. The Mortality After Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis. Int J Popul Data Sci. 2019;5(1):06.","journal-title":"Int J Popul Data Sci"},{"key":"346_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.drugalcdep.2017.05.001","volume":"178","author":"R McDonald","year":"2017","unstructured":"McDonald R, Campbell ND, Strang J. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids\u2014conception and maturation. Drug Alcohol Depend. 2017;178:176\u201387.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"346_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","volume":"8","author":"AK Clark","year":"2014","unstructured":"Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8(3):153\u201363.","journal-title":"J Addict Med"},{"issue":"7","key":"346_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addict. 2016;111(7):1177\u201387.","journal-title":"Addict."},{"key":"346_CR7","doi-asserted-by":"publisher","first-page":"107536","DOI":"10.1016\/j.drugalcdep.2019.06.038","volume":"204","author":"RB Naumann","year":"2019","unstructured":"Naumann RB, Durrance CP, Ranapurwala SI, Austin AE, Proscholdbell S, Childs R, et al. Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug Alcohol Depend. 2019;204:107536.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"346_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O'Brien KK, Colguhoun H, Levac D, et al. PRISMA extension for scoping review (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"7","key":"346_CR9","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"issue":"7","key":"346_CR10","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"346_CR11","volume-title":"Drug overdose deaths in the United States, 1999-2018. NCHS Data Brief, no 356","author":"H Hedegaard","year":"2020","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 1999-2018. NCHS Data Brief, no 356. Hyattsville: National Center for Health Statistics; 2020."},{"key":"346_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.drugpo.2017.05.015","volume":"46","author":"M Horton","year":"2017","unstructured":"Horton M, McDonald R, Green TC, Nielsen S, Strang J, Degenhardt L, et al. A mapping review of take-home naloxone for people released from correctional settings. Int J Drug Policy. 2017;46:7\u201316.","journal-title":"Int J Drug Policy"},{"key":"346_CR13","volume-title":"Constructing grounded theory: a practical guide through qualitative analysis","author":"K Charmaz","year":"2006","unstructured":"Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. Thousand Oaks: Sage; 2006."},{"issue":"4","key":"346_CR14","first-page":"320","volume":"19","author":"T Bennett","year":"2012","unstructured":"Bennett T, Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN project in Wales. Drugs (Abingdon Engl). 2012;19(4):320\u20138.","journal-title":"Drugs (Abingdon Engl)"},{"issue":"6","key":"346_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5055\/jom.2013.0181","volume":"9","author":"KL Cropsey","year":"2013","unstructured":"Cropsey KL, Martin S, Clark CB, McCullumsmith CB, Lane PS, Hardy S, et al. Characterization of opioid overdose and response in a high-risk community corrections sample: a preliminary study. J Opioid Manag. 2013;9(6):393\u2013400.","journal-title":"J Opioid Manag"},{"issue":"1","key":"346_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12954-018-0255-5","volume":"15","author":"M Curtis","year":"2018","unstructured":"Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, et al. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use. Harm Reduct J. 2018;15(1):48.","journal-title":"Harm Reduct J"},{"key":"346_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.addbeh.2018.12.017","volume":"92","author":"PJ Davidson","year":"2019","unstructured":"Davidson PJ, Wagner KD, Tokar PL, Scholar S. Documenting need for naloxone distribution in the Los Angeles County jail system. Addict Behav. 2019;92:20\u20133.","journal-title":"Addict Behav"},{"issue":"16","key":"346_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12954-019-0317-3","volume":"1","author":"RE Gicquelais","year":"2019","unstructured":"Gicquelais RE, Mezuk B, Foxman B, Thomas L, Bohnert ASB. Justice involvement patterns, overdose experiences, and naloxone knowledge among men and women in criminal justice diversion addiction treatment. Harm Reduct J. 2019;1(16):46.","journal-title":"Harm Reduct J"},{"key":"346_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugpo.2018.03.007","volume":"56","author":"K Holloway","year":"2018","unstructured":"Holloway K, Hills R, May T. Fatal and non-fatal overdose among opiate users in South Wales: a qualitative study of peer responses. Int J Drug Policy. 2018;56:56\u201363.","journal-title":"Int J Drug Policy"},{"key":"346_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.drugpo.2017.06.008","volume":"48","author":"S Koester","year":"2017","unstructured":"Koester S, Mueller SR, Raville L, Langegger S, Binswanger IA. Why are some people who have received overdose education and naloxone reticent to call emergency medical services in the event of overdose? Int J Drug Policy. 2017;48:115\u201324.","journal-title":"Int J Drug Policy"},{"key":"346_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-017-0200-z","volume":"14","author":"AG Petterson","year":"2017","unstructured":"Petterson AG, Madah-Amiri D. Overdose prevention training with naloxone distribution in a prison in Oslo, Norway: a preliminary study. Harm Reduct J. 2017;14:74.","journal-title":"Harm Reduct J"},{"key":"346_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.drugalcdep.2015.06.023","volume":"154","author":"JA Barocas","year":"2015","unstructured":"Barocas JA, Baker L, Hull SJ, Stokes S, Westergaard RP. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Drug Alcohol Depend. 2015;154:283\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"10073","key":"346_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(17)30656-6","volume":"389","author":"SM Bird","year":"2017","unstructured":"Bird SM, McAuley A, Munro A, Hutchinson SJ, Taylor A. Prison-based prescriptions aid Scotland's National Naloxone Programme. Lancet. 2017;389(10073):1005\u20136.","journal-title":"Lancet."},{"key":"346_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.drugalcdep.2016.02.031","volume":"162","author":"A McAuley","year":"2016","unstructured":"McAuley A, Munro A, Bird SM, Hutchinson SJ, Goldberg DJ, Taylor A. Engagement in a National Naloxone Programme among people who inject drugs. Drug Alcohol Depend. 2016;162:236\u201340.","journal-title":"Drug Alcohol Depend"},{"key":"346_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2017.05.017","volume":"46","author":"C O\u2019Hallaran","year":"2017","unstructured":"O\u2019Hallaran C, Cullen K, Njoroge J, Jessop L, Smith J, Hope V, et al. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland. Int J Drug Policy. 2017;46:34\u201340.","journal-title":"Int J Drug Policy"},{"issue":"10169","key":"346_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(18)33065-4","volume":"393","author":"SM Bird","year":"2019","unstructured":"Bird SM, McAuley A. Scotland's national naloxone programme. Lancet. 2019;393(10169):316\u20137.","journal-title":"Lancet."},{"key":"346_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/add.13265","volume":"111","author":"SM Bird","year":"2016","unstructured":"Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: A before (2006-10) versus after (2011-13) comparison. Addict. 2016;111:883\u201391.","journal-title":"Addict."},{"issue":"2","key":"346_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08897077.2013.825691","volume":"35","author":"TC Green","year":"2014","unstructured":"Green TC, Ray M, Bowman SE, McKenzie M, Rich JD. Two cases of intranasal naloxone self-administration in opioid overdose. Subst Abus. 2014;35(2):129\u201332.","journal-title":"Subst Abus"},{"key":"346_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.addbeh.2017.11.029","volume":"86","author":"Z Huxley-Reicher","year":"2018","unstructured":"Huxley-Reicher Z, Maldjian L, Winkelstein E, Siegler A, Paone D, Tuazon E, et al. Witnessed overdoses and naloxone use among visitors to Rikers Island jails trained in overdose rescue. Addict Behav. 2018;86:72\u20138.","journal-title":"Addict Behav"},{"key":"346_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/SIH.0000000000000182","volume":"12","author":"L Kobayashi","year":"2017","unstructured":"Kobayashi L, Green TC, Bowman SE, Ray MC, McKenzie MS, Rich JD. Patient simulation for assessment of layperson management of opioid overdose with intranasal naloxone in a recently-released prisoner cohort. Simul Healthc. 2017;12:22\u20137.","journal-title":"Simul Healthc"},{"key":"346_CR31","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/add.13668","volume":"112","author":"MKB Parmar","year":"2017","unstructured":"Parmar MKB, Strang J, Choo L, Meade AM, Bird SM. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths. Addict. 2017;112:502\u201315.","journal-title":"Addict."},{"issue":"25","key":"346_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1078345819882771","volume":"4","author":"LD Wenger","year":"2019","unstructured":"Wenger LD, Showalter D, Lambdin B, Leiva D, Wheeler E, Davidson PJ, et al. Overdose education and naloxone distribution in the San Francisco County Jail. J Correct Health Care. 2019;4(25):394\u2013404.","journal-title":"J Correct Health Care"},{"issue":"5","key":"346_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0017896914550321","volume":"75","author":"TC Green","year":"2015","unstructured":"Green TC, Bowman SE, Ray M, McKenzie M, Lord SE, Rich JD. Development of an incarceration-specific overdose prevention video: staying Alive on the outside. Health Educ J. 2015;75(5):627\u201337.","journal-title":"Health Educ J"},{"issue":"4","key":"346_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/dar.12542","volume":"37","author":"K Horsburgh","year":"2018","unstructured":"Horsburgh K, McAuley A. Scotland's national naloxone program: the prison experience. Drug Alcohol Rev. 2018;37(4):454\u20136.","journal-title":"Drug Alcohol Rev"},{"issue":"15","key":"346_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1108\/IJPH-12-2017-0058","volume":"1","author":"LA Pearce","year":"2019","unstructured":"Pearce LA, Mathany L, Rothon D, Kuo M, Buxton JA. An evaluation of take home naloxone program implementation in British Columbian correctional facilities. Int J Prison Health. 2019;1(15):46\u201357.","journal-title":"Int J Prison Health"},{"key":"346_CR36","first-page":"5","volume":"13","author":"A Sondhi","year":"2016","unstructured":"Sondhi A, Ryan G, Day E. Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England. Int J Drug Policy. 2016;13:5.","journal-title":"Int J Drug Policy"},{"key":"346_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12954-015-0084-8","volume":"12","author":"H Zucker","year":"2015","unstructured":"Zucker H, Annucci AJ, Stancliff S, Catania H. Overdose prevention for prisoners in New York: a novel program and collaboration. Harm Reduct J. 2015;12:51.","journal-title":"Harm Reduct J"},{"issue":"1","key":"346_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1078345816685311","volume":"23","author":"B Alex","year":"2017","unstructured":"Alex B, Weiss DB, Kaba F, Rosner Z, Lee D, Lim S, et al. Death after jail release: Matching to improve care delivery. J Correct Health Care. 2017;23(1):83\u20137.","journal-title":"J Correct Health Care"},{"issue":"17","key":"346_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12954-019-0354-y","volume":"1","author":"L Andersson","year":"2020","unstructured":"Andersson L, H\u00e5kansson A, Krantz P, Johnson B. Investigating opioid-related fatalities in southern Sweden: Contact with care-providing authorities and comparison of substances. Harm Reduct J. 2020;1(17):5.","journal-title":"Harm Reduct J"},{"key":"346_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1940-0640-7-3","volume":"7","author":"IA Binswanger","year":"2012","unstructured":"Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7:3.","journal-title":"Addict Sci Clin Pract"},{"key":"346_CR41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/add.13200","volume":"111","author":"IA Binswanger","year":"2016","unstructured":"Binswanger IA, Stern MF, Yamashita TE, Mueller SR, Baggett TP, Blatchford PJ. Clinical risk factors for death after release from prison in Washington State: A nested case\u2013control study. Addict. 2016;111:499\u2013510.","journal-title":"Addict."},{"key":"346_CR42","doi-asserted-by":"publisher","unstructured":"Binswanger IA, Nguyen AP, Morenoff JD, Xu S, Harding DJ. The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study. Addict. 2020; https:\/\/doi.org\/10.1111\/add.15077.","DOI":"10.1111\/add.15077"},{"key":"346_CR43","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/add.12969","volume":"110","author":"SM Bird","year":"2015","unstructured":"Bird SM, Fischbacher CM, Graham L, Fraser A. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release. Addict. 2015;110:1617\u201324.","journal-title":"Addict."},{"key":"346_CR44","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/add.13803","volume":"112","author":"A Bukten","year":"2017","unstructured":"Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T. High risk of overdose death following release from prison: variations in mortality during a 15-year observation period. Addict. 2017;112:1432\u20139.","journal-title":"Addict."},{"issue":"3","key":"346_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1108\/IJPH-03-2015-0007","volume":"11","author":"J Cepeda","year":"2015","unstructured":"Cepeda J, Vetrova M, Lyubimova AI, Levina OS, Heimer R, Niccolai LM. Community reentry challenges after release from prison among people who inject drugs in St. Petersburg, Russia. Int J Prison Health. 2015;11(3):183\u201392.","journal-title":"Int J Prison Health"},{"key":"346_CR46","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/add.14106","volume":"113","author":"SJ Forsyth","year":"2018","unstructured":"Forsyth SJ, Carroll M, Lennox N, Kinner SA. Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study. Addict. 2018;113:937\u201345.","journal-title":"Addict."},{"issue":"6","key":"346_CR47","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/0033354918803938","volume":"133","author":"K Hacker","year":"2018","unstructured":"Hacker K, Jones LD, Brink L, Wilson A, Cherna M, Dalton E, Hulsey EG. Linking opioid-overdose data to human services and criminal justice data: opportunities for intervention. Public Health Rep. 2018;133(6):658\u201366.","journal-title":"Public Health Rep"},{"key":"346_CR48","doi-asserted-by":"publisher","first-page":"107707","DOI":"10.1016\/j.drugalcdep.2019.107707","volume":"206","author":"C Keen","year":"2020","unstructured":"Keen C, Young JT, Borschmann R, Kinner SA. Non-fatal drug overdose after release from prison: a prospective data linkage study. Drug Alcohol Depend. 2020;206:107707.","journal-title":"Drug Alcohol Depend"},{"key":"346_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.addbeh.2012.01.019","volume":"37","author":"SA Kinner","year":"2012","unstructured":"Kinner SA, Milloy M-J, Wood E, Qi J, Zhang R, Kerr T. Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addict Behav. 2012;37:691\u20136.","journal-title":"Addict Behav"},{"key":"346_CR50","doi-asserted-by":"publisher","first-page":"107537","DOI":"10.1016\/j.drugalcdep.2019.06.039","volume":"204","author":"MR Larochelle","year":"2019","unstructured":"Larochelle MR, Bernstein R, Bernson D, Land T, Stopka TJ, Rose AJ, et al. Touchpoints - opportunities to predict and prevent opioid overdose: a cohort study. Drug Alcohol Depend. 2019;204:107537.","journal-title":"Drug Alcohol Depend"},{"key":"346_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.drugalcdep.2013.06.001","volume":"133","author":"E Moore","year":"2013","unstructured":"Moore E, Winter R, Indig D, Greenberg D, Kinner SA. Non-fatal overdose among adult prisoners with a history of injecting drug use in two Australian states. Drug Alcohol Depend. 2013;133:45\u201351.","journal-title":"Drug Alcohol Depend"},{"key":"346_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.drugalcdep.2018.04.034","volume":"189","author":"LN Pizzicato","year":"2018","unstructured":"Pizzicato LN, Drake R, Domer-Shank R, Johnson CC, Viner KM. Beyond the walls: risk factors for overdose mortality following release from the Philadelphia Department of Prisons. Drug Alcohol Depend. 2018;189:108\u201315.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"346_CR53","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","volume":"109","author":"SI Ranapurwala","year":"2018","unstructured":"Ranapurwala SI, Shanahan ME, Alexandridis AA, Proescholdbell SK, Naumann RB, Edwards D, et al. Opioid overdose mortality among former North Carolina inmates: 2000-2015. Am J Public Health. 2018;109(9):1207\u201313.","journal-title":"Am J Public Health"},{"issue":"28","key":"346_CR54","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1017\/S2045796017000506","volume":"2","author":"MJ Spittal","year":"2019","unstructured":"Spittal MJ, Forsyth S, Borschmann R, Young JT, Kinner SA. Modifiable risk factors for external cause mortality after release from prison: a nested case-control study. Epidemiol Psychiatr Sci. 2019;2(28):224\u201333.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"346_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.drugalcdep.2015.05.026","volume":"153","author":"KD Wagner","year":"2015","unstructured":"Wagner KD, Liu L, Davidson PJ, Cuevas-Mota J, Armenta RF, Garfein RS. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: identifying opportunities for intervention. Drug Alcohol Depend. 2015;153:215\u201320.","journal-title":"Drug Alcohol Depend"},{"key":"346_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drugalcdep.2015.06.011","volume":"153","author":"RJ Winter","year":"2015","unstructured":"Winter RJ, Stoov\u00e9 M, Degenhardt L, Hellard ME, Spelman T, Jenkinson R, et al. Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia. Drug Alcohol Depend. 2015;153:43\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"346_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/09687637.2014.981509","volume":"22","author":"SM Bird","year":"2015","unstructured":"Bird SM, Parmar MKB, Strang J. Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland\u2019s public health policy evaluation, and a new measure to assess impact. Drugs Educ Prev Policy. 2015;22:66\u201376.","journal-title":"Drugs Educ Prev Policy"},{"key":"346_CR58","doi-asserted-by":"publisher","first-page":"105813","DOI":"10.1016\/j.ypmed.2019.105813","volume":"128","author":"SM Bagley","year":"2019","unstructured":"Bagley SM, Schoenberger SF, Waye FM, Walley AY. A scoping review of post opioid-overdose interventions. Prev Med. 2019;128:105813.","journal-title":"Prev Med"},{"key":"346_CR59","doi-asserted-by":"publisher","first-page":"e011224","DOI":"10.1136\/bmjopen-2016-011224","volume":"6","author":"G Ambrose","year":"2016","unstructured":"Ambrose G, Amlani A, Buxton JA. Predictors of seeking emergency medical help during overdose events in a provincial naloxone distribution programme: a retrospective analysis. BMJ Open. 2016;6:e011224.","journal-title":"BMJ Open"},{"issue":"1","key":"346_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12954-018-0226-x","volume":"15","author":"DP Watson","year":"2018","unstructured":"Watson DP, Ray B, Robison L, Huynh P, Sightes E, Brucker K, et al. Lay responder naloxone access and good Samaritan law compliance: postcard survey results from 20 Indiana counties. Harm Reduct J. 2018;15(1):18.","journal-title":"Harm Reduct J"},{"issue":"11","key":"346_CR61","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11920-013-0414-z","volume":"15","author":"S Belenko","year":"2013","unstructured":"Belenko S, Hiller M, Hamilton L. Treating substance use disorders in the criminal justice system. Curr Psychiatry Rep. 2013;15(11):414.","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"346_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08897077.2011.611460","volume":"33","author":"PD Friedmann","year":"2012","unstructured":"Friedmann PD, Hoskinson R, Godon M, Schwartz R, Kinlock T, Knight K, et al. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug Abuse treatment studies (CJ-DATS): availability, barriers & intentions. Subst Abus. 2012;33(1):9\u201318.","journal-title":"Subst Abus"},{"issue":"1","key":"346_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/08897077.2015.1129389","volume":"37","author":"SG Mitchell","year":"2016","unstructured":"Mitchell SG, Willet J, Monico LB, James A, Rudes DS, Viglione J, et al. Community correctional agents\u2019 views of medication-assisted treatment: examining their influence on treatment referrals and community supervision practices. Subst Abus. 2016;37(1):127\u201333.","journal-title":"Subst Abus"},{"issue":"1","key":"346_CR64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.0887-378X.2004.00304.x","volume":"82","author":"S Burris","year":"2004","unstructured":"Burris S, Blankenship KM, Donoghoe M, Sherman S, Vernick JS, Case P, et al. Addressing the \u201crisk environment\u201d for injection drug users: the mysterious case of the missing cop. Milbank Q. 2004;82(1):125\u201356.","journal-title":"Milbank Q"},{"key":"346_CR65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.drugpo.2008.08.008","volume":"20","author":"HLF Cooper","year":"2009","unstructured":"Cooper HLF, Bossak B, Tempalski B, Des Jarlais DC, Friedman SR. Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes. Int J Drug Policy. 2009;20:217\u201326.","journal-title":"Int J Drug Policy"},{"key":"346_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13:85\u201394.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"346_CR67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","volume":"26","author":"MJ Grant","year":"2009","unstructured":"Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J. 2009;26(2):91\u2013108.","journal-title":"Health Inf Libr J"},{"key":"346_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:1\u20139.","journal-title":"Implement Sci"},{"key":"346_CR69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","volume":"50","author":"PD Friedmann","year":"2015","unstructured":"Friedmann PD, Wilson D, Knudsen HK, Ducharme LJ, Welsh WN, Frisman L, et al. Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. J Subst Abus Treat. 2015;50:50\u20138.","journal-title":"J Subst Abus Treat"},{"key":"346_CR70","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10488-014-0623-8","volume":"43","author":"WN Welsh","year":"2016","unstructured":"Welsh WN, Knudsen HK, Knight K, Ducharme L, Pankow J, Urbine T, et al. Effects of an organizational linkage intervention on inter-organizational service coordination between probation\/parole agencies and community treatment providers. Admin Pol Ment Health. 2016;43:105\u201321.","journal-title":"Admin Pol Ment Health"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-021-00346-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T08:06:04Z","timestamp":1674979564000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-021-00346-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1186\/s13011-021-00346-1","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"13 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was an analysis of preexisting literature and did not use human subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}